Jabby is a medication tracker for GLP-1 users to monitor injection sites, weight, and side effects on iOS.
The App DNA
What makes this app unique?
Patients use Jabby to maintain treatment adherence and organize health data for doctor appointments without the friction of manual account sign-ups.
For Patients prescribed GLP-1 medications who require a structured tool to track doses, side effects, and weight progress.
What does it look like?
Key features
Visual tracker for injection sites to ensure rotation, preventing site-specific tissue issues.
Imports weight, protein, carbs, fat, and fiber data directly from Apple Health.
Generates a summary report of doses and weight trends for doctor appointments.
How much does it cost?
Freemium model gates advanced reporting and premium features behind an auto-renewing subscription.
Velocity
Maintenance developmentUX improvementsnew contentShow more...
Jabby GLP-1 Medication Tracker exhibits a maintenance-level cadence, with two releases identified in the recent window. The latest version represents a major update by introducing functional widget support for iOS, while the preceding release provided no public notes. Development appears focused on utility and UX improvements rather than rapid iteration. The current release frequency remains consistent with a stable, low-velocity maintenance cycle.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews mixed. Users appreciate personalized medication tracking features allow users to tailor the experience to their specific health needs and responsive customer support helps users resolve initial setup issues like font scaling problems quickly.
How are ratings & reviews evolving?
What users say, by theme
- Personalized medication tracking features allow users to tailor the experience to their specific health needs
- Responsive customer support helps users resolve initial setup issues like font scaling problems quickly
- Application crashes immediately upon launch following the latest update, preventing access for paid users
9 of 9 recent reviews analyzed · limited sample · Mixed overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Jabby GLP-1 Medication Tracker
How's the Health & Fitness market?
Jabby operates in the Health & Fitness category, maintaining a 4.5 rating across 52 total ratings. The recent release cadence of two updates in two months shows active maintenance, though the latest build's instability threatens the current user base.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Jabby GLP-1 Medication Tracker
Where is it heading?
The outlook for Jabby is declining due to severe stability issues in the latest release. Resolving these technical regressions is critical to restoring user trust and preventing the loss of the current subscriber base.
- Critical launch crashes in the latest version block access for paid users, leading to immediate churn and negative sentiment.
- Data synchronization errors with external health platforms cause incorrect weight calculations, which degrades the core utility of the tracking features.
The SWOT
- Injection site rotation tracker provides specific utility for chronic medication management
- Private iCloud sync ensures data portability without requiring account sign-ups
- Adding a photo-based progress gallery would address the top user request
Next best moves
Hotfix the launch crash because it is the primary blocker for paid users → restore access
+ 1 more prioritized moveThe counter-intuitive read
The lack of account sign-ups is a retention risk…
Read the full takeBottom line
Restoring stability is the immediate priority, as the current launch crash invalidates the value proposition for paid users. Addressing the data sync errors will then secure the app's role as a reliable health logbook, preventing churn to manual alternatives.
Unlock 3 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated